Sudan vs Upper middle income: Prevalence of hypertension, female
Sudan
43.5%
in 2019
Upper middle income
30.4%
in 2019
Sudan rank
30th
Upper middle income rank
33rd
Prevalence of hypertension, female over time
- Sudan
- Upper middle income
How they compare
Sudan currently reports 43.5% against 30.4% in Upper middle income, a difference of 13.1%.
That makes Sudan's figure about 1.4 times Upper middle income's.
Across all 30 years both countries report, Sudan has been ahead every year.
Sudan ranks 30th and Upper middle income ranks 33rd of 192 countries.
Sudan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sudan | Upper middle income | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 38.8% | 28.5% | 10.3% | Sudan |
| 2000s | 41.7% | 31.1% | 10.6% | Sudan |
| 2010s | 43.6% | 31.4% | 12.3% | Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hypertension, female, Sudan or Upper middle income?
- Sudan, at 43.5% against 30.4% in Upper middle income as of 2019.
- What is the difference in prevalence of hypertension, female between Sudan and Upper middle income?
- 13.1%, with Sudan ahead.
- How many years of comparable data are there for Sudan and Upper middle income?
- 30 years are reported by both, from 1990 to 2019.
- How do Sudan and Upper middle income rank globally for prevalence of hypertension, female?
- Sudan ranks 30th and Upper middle income ranks 33rd of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Prevalence of hypertension, female (% of female adults ages 30-79). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of hypertension, female, is the percentage of female adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.